This stock shocked the market with a $1 special dividend, fueling a massive rally of more than 230%. The unexpected payout sent a strong message about financial stability and shareholder focus.
Ahead of the Rally (Sponsored)
Q3 2025 is moving fast, and the strongest setups aren’t waiting around.
We’ve just released a free guide revealing 7 stocks showing clear breakout potential this quarter.
From sectors positioned to surge to companies overlooked by Wall Street, these are the kinds of names early movers look for.
The research is simple, actionable, and designed to help investors move with confidence.
[Unlock Your Free Guide Now Before Momentum Takes Off]
Markets
U.S. stocks rose Thursday, with the S&P 500 hitting a record high as stronger-than-expected GDP growth and upbeat earnings from major tech names offset concerns over Nvidia’s data center miss.
DJIA [+0.16%]
S&P 500 [+0.32%]
Nasdaq [+0.53%]
Russell 2k [+0.22%]
Market-Moving News
Pharmaceuticals
AbbVie Expands Into Psychiatry With $1.2B Acquisition of Gilgamesh Asset
AbbVie (NYSE: ABBV) has agreed to acquire Bretisilocin, a late-stage candidate for major depressive disorder, from Gilgamesh Pharmaceuticals for up to $1.2 billion.
The deal secures global rights to a therapy that has demonstrated meaningful clinical benefits in early trials, including a rapid reduction in depressive symptoms without major safety concerns.
This acquisition underscores AbbVie’s determination to diversify beyond its core immunology portfolio, which has been pressured by the erosion of biosimilar competition for Humira.
By entering psychiatry, AbbVie is targeting a therapeutic area with both high unmet medical needs and commercial potential.
The transaction signals a willingness to pursue innovative, high-risk assets that could create entirely new revenue streams in the next decade.
Those evaluating an entry position should recognize how this shift strengthens AbbVie’s long-term growth profile.
Psychiatric treatments represent a multi-billion-dollar global market, where few large pharmaceutical companies have established leadership.
If Bretisilocin advances successfully, AbbVie could secure a first-mover advantage among large biopharma peers in modern psychedelic-based therapies.
For shareholders, the acquisition highlights AbbVie’s strategic use of capital to secure optionality in high-growth therapeutic categories, reinforcing its commitment to sustaining revenue momentum.
Streaming
Amazon Expands Streaming Ecosystem as Peacock Joins Prime Video Channels
Amazon (NASDAQ: AMZN) has added NBCUniversal’s Peacock service to Prime Video Channels, giving U.S. customers the ability to subscribe to the ad-free Premium Plus tier directly through Amazon for $16.99 per month.
The agreement also renews Peacock’s placement on Fire TV, extends Universal Pictures rentals and purchases on Prime Video, and ensures Prime Video’s ongoing distribution on Comcast’s X1 platform.
For investors with positions in Amazon, the deal underscores how the company is transforming Prime Video into a subscription hub rather than a standalone competitor.
Every third-party service added through Prime strengthens engagement across Amazon’s ecosystem, reducing churn and expanding the monetization base beyond retail and advertising.
By becoming the primary gateway to a fragmented streaming market, Amazon creates recurring revenue while reinforcing the long-term value of Prime membership.
For those considering entry, the significance lies in Amazon’s role as a “super distributor.”
Unlike streaming rivals that rely on costly content production, Amazon generates revenue through aggregation, bundling, and leveraging its platform.
This strategy enhances negotiation leverage with media companies and creates valuable data advantages that competitors, such as Roku and Apple, are also pursuing, albeit on a smaller scale.
The Peacock agreement highlights Amazon’s strategic intent to position Prime Video as infrastructure for the streaming economy, deepening ecosystem lock-in and extending optionality for future growth.
Hidden Stock Move (Sponsored)
The smartest investors don’t chase headlines.
They look for undervalued opportunities before the mainstream catches on.
Zacks has done the work and identified 5 AI stocks primed for growth — including one sleeper company still being overlooked.
This could be your chance to position early in the next big shift — just as AI is reshaping the economy.
[Download your free copy today]
Communications
The $23 Billion Catalyst: Why EchoStar's Rally Is Just Getting Started
EchoStar's (NASDAQ: SATS) stock just experienced a transformative event. A $23 billion asset sale to AT&T has completely reset the company's financial future.
This was a strategic masterstroke, as the deal addresses EchoStar's massive $26.5 billion debt load and removes its most significant economic risk in a single move.
The true significance of this transaction is the shift it enables for the company.
With its balance sheet fortified, EchoStar can now pivot from a defensive posture to an offensive strategy focused on growth.
The deal provides the financial firepower to fund its ambitious $5 billion direct-to-device (D2D) satellite constellation, an initiative that would have been far riskier without this cash infusion.
During this period, the company's investment thesis has undergone a fundamental change.
The new key question is not whether EchoStar can survive its debt, but how effectively it can execute on its well-funded, ambitious strategy.
This latest chapter of execution risk has just begun, and its valuable portfolio of S-band spectrum is a key competitive advantage in the D2D market that investors should now be focused on.
The company's dramatic short-covering and explosive trading volume following the announcement signal that this is more than just a passing rally; the market's re-evaluation is real.
While competition from players like SpaceX is fierce, EchoStar's newly fortified balance sheet and key spectrum assets position it as a serious contender in the high-stakes satellite connectivity race.
Want to make sure you never miss our post-market roundup?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone right after the closing bell rings.
Email’s great. Texts are faster.
Top Winners and Losers
Sound Group Inc [SOGP] $12.32 (+230.51%)
Sound Group rallied after declaring a special $1.00 dividend per ADS, signaling strong financial health and rewarding shareholders.
Agrify Corporation [AGFY] $45.88 (+50.33%)
Agrify surged after acquiring premium cannabis brands like RYTHM and Dogwalkers from Green Thumb, rebranding itself and securing licensing revenue streams.
Pure Storage Inc [PSTG] $80.58 (+32.40%)
Pure Storage soared after smashing Q2 expectations and raising full-year guidance, buoyed by strong enterprise demand and subscription growth.
Cel-Sci Corp [CVM] $9.31 (-28.64 %)
CEL-SCI dropped after pricing a $10 million public offering at a discount, sparking dilution concerns among investors.
Accelerant Holdings [ARX] $21.61 (-26.24%)
Accelerant slipped despite strong Q2 results, as investors took profits following its IPO and eyed slowing premium growth momentum.
Malibu Boats Inc [MBUU] $32.80 (-17.00%)
Malibu Boats sank after missing EPS and EBITDA expectations, with investors shrugging off its revenue beat and focusing on profitability weakness.
Poll: If your budget could talk back, what would it say?
Breakout Watchlist Ready (Sponsored)
When markets shift, opportunities emerge. But the best ones rarely stay hidden for long.
Our analysts have pinpointed 5 companies that stand out for their fundamentals, momentum, and potential to double from here.
You’ll find them inside the new 5 Stocks Set to Double report—free for a limited time.
Past versions of this report uncovered stocks that went on to massive gains of +175%, +498%, even +673%.¹
Today, you can download your copy instantly.
But once the clock strikes midnight, this free access closes.
Big winners don’t wait. Neither should you.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Everything Else
The EU will remove tariffs on a range of U.S. goods, clearing a path for lower duties on cars.
Nike plans to cut about 1% of its corporate workforce as part of a broader effort to streamline its business.
Intel has secured $5.7 billion in pending CHIPS Act grants as part of a deal with the Trump administration.
Phillips 66 will begin shutting down its Los Angeles refinery in a major operational shift.
Nippon Steel is committing $11 billion and a major technology transfer in hopes of boosting profitability at U.S. Steel.
Chinese shipping giant COSCO has admitted to facing hurdles in its international investments due to growing U.S. trade pressure.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
